Astellas Pharma Stock Forecast - Naive Prediction
| YPH Stock | EUR 9.50 0.20 2.15% |
The Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 9.53 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.81. Astellas Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Astellas Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Astellas |
Astellas Pharma Naive Prediction Price Forecast For the 28th of November
Given 90 days horizon, the Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 9.53 with a mean absolute deviation of 0.14, mean absolute percentage error of 0.03, and the sum of the absolute errors of 8.81.Please note that although there have been many attempts to predict Astellas Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Astellas Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Astellas Pharma Stock Forecast Pattern
| Backtest Astellas Pharma | Astellas Pharma Price Prediction | Buy or Sell Advice |
Astellas Pharma Forecasted Value
In the context of forecasting Astellas Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Astellas Pharma's downside and upside margins for the forecasting period are 7.35 and 11.72, respectively. We have considered Astellas Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Astellas Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Astellas Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.7394 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1444 |
| MAPE | Mean absolute percentage error | 0.0138 |
| SAE | Sum of the absolute errors | 8.8075 |
Predictive Modules for Astellas Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Astellas Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Astellas Pharma
For every potential investor in Astellas, whether a beginner or expert, Astellas Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Astellas Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Astellas. Basic forecasting techniques help filter out the noise by identifying Astellas Pharma's price trends.Astellas Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Astellas Pharma stock to make a market-neutral strategy. Peer analysis of Astellas Pharma could also be used in its relative valuation, which is a method of valuing Astellas Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Astellas Pharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Astellas Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Astellas Pharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Astellas Pharma Market Strength Events
Market strength indicators help investors to evaluate how Astellas Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By undertsting and applying Astellas Pharma stock market strength indicators, traders can identify Astellas Pharma entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 9.5 | |||
| Day Typical Price | 9.5 | |||
| Price Action Indicator | 0.1 | |||
| Period Momentum Indicator | 0.2 | |||
| Relative Strength Index | 60.22 |
Astellas Pharma Risk Indicators
The analysis of Astellas Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Astellas Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astellas stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.62 | |||
| Standard Deviation | 2.18 | |||
| Variance | 4.77 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Astellas Stock
Astellas Pharma financial ratios help investors to determine whether Astellas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Astellas with respect to the benefits of owning Astellas Pharma security.